4th Annual RAD Conference - April 9-11, 2022 - In Person

Although diagnosis of Atopic Dermatitis (AD) is straightforward in children, its diagnosis is challenging in adults. Advances in research on AD epidemiology, burden and comorbidities have transformed the understanding of the course of AD, including risk factors, age of onset, disease severity and persistence, and health outcomes. Clinicians may not be aware of the epidemiology of AD for proper risk stratification, patient education and therapeutic decision-making. Atopic dermatitis is a heterogeneous disorder with variable severity of signs and symptoms, and impact on quality of life. Clinicians may not be able to assess AD severity accurately in order to optimize therapy.

Our Conference allows clinicians to understand this disease better through the latest in research, expert faculty speakers, late-breaking research and Q&A sessions.

Target Audience

This program is intended for dermatologists, allergists and immunologists, primary care clinicians, NPs/RNs/APRNs, physician assistants and other allied health professionals as well as patients/patient groups engaged in the care of patients with Atopic Dermatitis (AD).

Educational Objectives

After completing this activity, upon diagnosis and assessment of severity of AD, the participant should be better able to:

  • Use evidence-based treatment approaches for atopic dermatitis
  • Translate improved understanding of pathophysiology, disease course and current, available treatment options to therapeutic decision making for atopic dermatitis and related comorbidities
  • Describe the remaining unmet needs in the treatment of atopic dermatitis
  • Discuss emerging therapies in the treatment of atopic dermatitis

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Foundation for Dermatology Education. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The Postgraduate Institute for Medicine designates this live activity for a maximum 14.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The maximum number of hours awarded for this Continuing Nursing Education activity is 14.25 contact hours.


Important: The 4th Annual RAD Conference will be held live, in person in Baltimore, Maryland, USA, as well as virtually. If you plan to attend the in person meeting, you must read and agree to a COVID-19 Waiver. If you do not wish to agree to the Waiver, you must register for the virtual meeting.
Please note that you will not receive an email confirming registration until after the fee has been paid. If you have a discount code, please enter the code when registering. Once you do so and complete the required registration information, you will receive a confirmation email.

Registration Rates - In Person Conference

Early-Bird Rates
February 1-28, 2022
March 1-20, 2022
March 21-April 11, 2022
Physicians $200 $300 $400
RNs, NPs, APRNs, PAs $125 $175 $225
Residents and Fellows $75 $100 $125
Industry - Exhibits and Scientific Sessions $350 $500 $750
Students $25 $50 $75
Patients $25 $50 $75

If you are a patient or member of the media, and you are interested in attending the Conference, please contact Patrice Melluso: patrice@revolutionizingad.com

If you registered for the program and did not receive your registration confirmation with the link to access the program, please check your spam/junk folder. If you are unable to find the email, please email Donna Jimenez: djimenez@dnadigitalgroup.com